Encompass Health Joins Other Companies in Amending or Adopting Clawback Policies
By Josh Beckerman
Encompass Health amended its clawback policy, including new terms to comply with a Securities and Exchange Commission rule approved last October related to recovery of erroneously awarded incentive-based compensation.
Encompass said its amendment provides for the company's mandatory recovery of erroneously awarded executive compensation in the event of an accounting restatement.
In June, Uber amended its clawback policy, with an Oct. 2 effective date, in order to comply with the SEC's final rules. Also in June, WD-40 adopted a clawback policy, which becomes effective Oct. 2. Victoria's Secret adopted a clawback policy last November.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
July 25, 2023 19:14 ET (23:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back